Viewing Company
Company Name:
Stoke Therapeutics, Inc.
CIK:
1623526
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2019-08-14
Last Filing Date:
2025-05-13
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2019-04-01 | 2019-06-30 | CY2018Q2 | 2019-08-14 | 0001564590-19-032126 | $ 5,083,620 | View |
| 2019-07-01 | 2019-09-30 | CY2018Q3 | 2019-11-12 | 0001564590-19-042891 | $ 32,707,647 | View |
| 2019-01-01 | 2019-12-31 | CY2018 | 2020-03-23 | 0001564590-20-012202 | $ 17,971,443 | View |
| 2020-01-01 | 2020-03-31 | CY2019Q1 | 2020-05-15 | 0001564590-20-025637 | $ 32,897,395 | View |
| 2020-04-01 | 2020-06-30 | CY2019Q2 | 2020-08-10 | 0001564590-20-038905 | $ 33,054,656 | View |
| 2020-07-01 | 2020-09-30 | CY2019Q3 | 2020-11-12 | 0001564590-20-053586 | $ 33,273,597 | View |
| 2020-01-01 | 2020-12-31 | CY2019 | 2021-03-09 | 0001564590-21-011760 | $ 33,488,456 | View |
| 2021-01-01 | 2021-03-31 | CY2020Q1 | 2021-05-10 | 0001564590-21-026040 | $ 36,643,205 | View |
| 2021-04-01 | 2021-06-30 | CY2021Q2 | 2021-08-10 | 0001564590-21-043072 | $ 36,708,188 | View |
| 2021-07-01 | 2021-09-30 | CY2021Q3 | 2021-11-08 | 0001564590-21-055240 | $ 36,759,319 | View |
| 2021-01-01 | 2021-12-31 | CY2021 | 2022-03-10 | 0001564590-22-009634 | $ 40 | View |
| 2022-01-01 | 2022-03-31 | CY2022Q1I | 2022-05-10 | 0001564590-22-019268 | $ 3,000,000 | View |
| 2022-04-01 | 2022-06-30 | CY2021Q2 | 2022-08-08 | 0001564590-22-028440 | $ 39,258,358 | View |
| 2022-07-01 | 2022-09-30 | CY2021Q3 | 2022-11-14 | 0001564590-22-037497 | $ 39,420,310 | View |
| 2022-01-01 | 2022-12-31 | CY2021Q4I | 2023-03-06 | 0001564590-23-003175 | $ 10,932,000 | View |
| 2023-01-01 | 2023-03-31 | CY2023Q1I | 2023-05-04 | 0000950170-23-017839 | $ 10,191,000 | View |
| 2023-04-01 | 2023-06-30 | CY2023Q2I | 2023-08-07 | 0000950170-23-039050 | $ 10,950,000 | View |
| 2023-07-01 | 2023-09-30 | CY2023Q3I | 2023-11-07 | 0000950170-23-060224 | $ 10,936,000 | View |
| 2023-01-01 | 2023-12-31 | CY2022Q4I | 2024-03-25 | 0000950170-24-035912 | $ 11,320,000 | View |
| 2024-04-01 | 2024-06-30 | CY2024Q2I | 2024-08-07 | 0000950170-24-092738 | $ 10,345,000 | View |
| 2024-01-01 | 2024-03-31 | CY2024Q1I | 2024-05-06 | 0000950170-24-053535 | $ 402,000 | View |
| 2024-07-01 | 2024-09-30 | CY2024Q3I | 2024-11-05 | 0000950170-24-121445 | $ 29,952,000 | View |
| 2024-01-01 | 2024-12-31 | CY2024 | 2025-03-18 | 0000950170-25-041170 | $ -12,391,000 | View |
| 2025-01-01 | 2025-03-31 | CY2025Q1 | 2025-05-13 | 0000950170-25-070296 | $ 114,157,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Proceeds from Stock Plans | The cash inflow associated with the amount received from the stock plan during the period. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accrued Professional Fees, Current | Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. | View |
| us-gaap | Share-based Payment Arrangement, Expense | Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. | View |
| us-gaap | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Debt Securities, Available-for-sale, Amortized Cost | Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Debt Securities, Available-for-sale, Current | Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current. | View |
| us-gaap | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | View |
| us-gaap | Conversion of Stock, Amount Issued | "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Debt Issuance Costs, Current, Net | Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Other | Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. | View |
| us-gaap | Deferred Tax Assets, Tax Credit Carryforwards, Research | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Defined Contribution Plan, Cost | Amount of cost for defined contribution plan. | View |
| us-gaap | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Percent | Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | Amount of cost not yet recognized for nonvested award under share-based payment arrangement. | View |
| us-gaap | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy. | View |
| us-gaap | Gain (Loss) on Disposition of Property Plant Equipment | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Impairment of Long-Lived Assets Held-for-use | The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). | View |
| us-gaap | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. | View |
| us-gaap | Increase (Decrease) in Deferred Liabilities | Change during the period in carrying value for all deferred liabilities due within one year or operating cycle. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. | View |
| us-gaap | Interest Income (Expense), Nonoperating, Net | The net amount of nonoperating interest income (expense). | View |
| us-gaap | Interest Receivable, Current | Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. | View |
| us-gaap | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. | View |
| us-gaap | Operating Leases, Rent Expense | Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid | Amount of lessee's undiscounted obligation for lease payment for operating lease. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Four | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Three | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Two | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year. | View |
| us-gaap | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease. | View |
| us-gaap | Liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Operating Lease, Expense | Amount of operating lease expense. Excludes sublease income. | View |
| us-gaap | Operating Lease, Liability | Present value of lessee's discounted obligation for lease payments from operating lease. | View |
| us-gaap | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. | View |
| us-gaap | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. | View |
| us-gaap | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. | View |
| us-gaap | Operating Leases, Future Minimum Payments Due | Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Four Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Three Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Two Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Lease, Weighted Average Discount Rate, Percent | Weighted average discount rate for operating lease calculated at point in time. | View |
| us-gaap | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). | View |
| us-gaap | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. | View |
| us-gaap | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. | View |
| us-gaap | Payments of Financing Costs | The cash outflow for loan and debt issuance costs. | View |
| us-gaap | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. | View |
| us-gaap | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. | View |
| us-gaap | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. | View |
| us-gaap | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Preferred Stock, Shares Issued | Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. | View |
| us-gaap | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | View |
| us-gaap | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Issuance Initial Public Offering | The cash inflow associated with the amount received from entity's first offering of stock to the public. | View |
| us-gaap | Proceeds from Issuance of Convertible Preferred Stock | The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. | View |
| us-gaap | Proceeds from (Payments for) Other Financing Activities | Amount of cash inflow (outflow) from financing activities classified as other. | View |
| us-gaap | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. | View |
| us-gaap | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. | View |
| us-gaap | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Restricted Cash and Cash Equivalents | Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Restricted Cash, Current | Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. | View |
| us-gaap | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | The risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | The maximum risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | Weighted average price of options that were either forfeited or expired. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Number of options outstanding, including both vested and non-vested options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | Weighted average price at which option holders acquired shares when converting their stock options into shares. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. | View |
| us-gaap | Stockholders' Equity Note, Stock Split, Conversion Ratio | Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | View |
| us-gaap | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. | View |
| us-gaap | Unrecognized Tax Benefits | Amount of unrecognized tax benefits. | View |
| us-gaap | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. | View |
| us-gaap | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
| us-gaap | Debt Securities, Available-for-sale, Allowance for Credit Loss | Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. | View |
| us-gaap | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. | View |
| us-gaap | Deferred Revenue, Noncurrent | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. | View |
| us-gaap | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. | View |
| us-gaap | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. | View |
| us-gaap | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Deferred Tax Assets, in Process Research and Development | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. | View |
| us-gaap | Other Assets, Current | Amount of current assets classified as other. | View |
| us-gaap | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Debt Securities, Available-for-sale | Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Deferred Costs, Current | Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer. | View |
| us-gaap | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Debt Securities, Available-for-sale, Noncurrent | Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent. | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| us-gaap | Accrued Employee Benefits, Current | Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year One | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Number of Operating Segments | Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. | View |
| us-gaap | Operating Leases, Future Minimum Payments Due, Next Twelve Months | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Property, Plant and Equipment, Gross | Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. | View |
| us-gaap | Interest Expense | Amount of the cost of borrowed funds accounted for as interest expense. | View |
| us-gaap | Number of Reportable Segments | Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. | View |
| us-gaap | 4240227 | None | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Common Stock, Shares Authorized | View |
| Common Stock, Shares, Issued | View |
| Accounts Payable, Current | View |
| Accrued Employee Benefits, Current | View |
| Accrued Professional Fees, Current | View |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | View |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | View |
| Additional Paid in Capital | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | View |
| Share-based Payment Arrangement, Expense | View |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | View |
| Assets | View |
| Assets, Current | View |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | View |
| Debt Securities, Available-for-sale, Amortized Cost | View |
| Debt Securities, Available-for-sale, Current | View |
| Capital Expenditures Incurred but Not yet Paid | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Value, Issued | View |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | View |
| Conversion of Stock, Amount Issued | View |
| Debt Issuance Costs, Current, Net | View |
| Deferred Tax Assets, Gross | View |
| Deferred Tax Assets, Net | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Other | View |
| Depreciation | View |
| Earnings Per Share, Basic and Diluted | View |
| Effective Income Tax Rate Reconciliation, Percent | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | View |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | View |
| Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | View |
| Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | View |
| Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | View |
| Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | View |
| Gain (Loss) on Disposition of Property Plant Equipment | View |
| General and Administrative Expense | View |
| Impairment of Long-Lived Assets Held-for-use | View |
| Income Tax Expense (Benefit) | View |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | View |
| Increase (Decrease) in Deferred Liabilities | View |
| Increase (Decrease) in Prepaid Expense and Other Assets | View |
| Interest Income (Expense), Nonoperating, Net | View |
| Interest Receivable, Current | View |
| Investment Income, Interest | View |
| Operating Leases, Rent Expense | View |
| Lessee, Operating Lease, Liability, to be Paid | View |
| Lessee, Operating Lease, Liability, to be Paid, Year One | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Four | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Three | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Two | View |
| Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | View |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount | View |
| Liabilities | View |
| Liabilities and Equity | View |
| Liabilities, Current | View |
| Liabilities, Noncurrent | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Income (Loss) Attributable to Parent | View |
| Nonoperating Income (Expense) | View |
| Number of Operating Segments | View |
| Operating Expenses | View |
| Operating Income (Loss) | View |
| Operating Lease, Expense | View |
| Operating Lease, Liability | View |
| Operating Lease, Liability, Current | View |
| Operating Lease, Liability, Noncurrent | View |
| Operating Lease, Right-of-Use Asset | View |
| Operating Leases, Future Minimum Payments Due | View |
| Operating Leases, Future Minimum Payments Due, Next Twelve Months | View |
| Operating Leases, Future Minimum Payments, Due in Four Years | View |
| Operating Leases, Future Minimum Payments, Due in Three Years | View |
| Operating Leases, Future Minimum Payments, Due in Two Years | View |
| Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | View |
| Operating Lease, Weighted Average Discount Rate, Percent | View |
| Other Comprehensive Income (Loss), Net of Tax | View |
| Other Liabilities, Current | View |
| Other Nonoperating Income (Expense) | View |
| Payments of Financing Costs | View |
| Payments of Stock Issuance Costs | View |
| Payments to Acquire Marketable Securities | View |
| Payments to Acquire Property, Plant, and Equipment | View |
| Preferred Stock, Par or Stated Value Per Share | View |
| Preferred Stock, Shares Authorized | View |
| Preferred Stock, Shares Issued | View |
| Preferred Stock, Shares Outstanding | View |
| Prepaid Expense and Other Assets, Current | View |
| Proceeds from Issuance Initial Public Offering | View |
| Proceeds from Issuance of Convertible Preferred Stock | View |
| Proceeds from (Payments for) Other Financing Activities | View |
| Proceeds from Sale of Property, Plant, and Equipment | View |
| Proceeds from Stock Options Exercised | View |
| Proceeds from Stock Plans | View |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | View |
| Property, Plant and Equipment, Gross | View |
| Property, Plant and Equipment, Net | View |
| Research and Development Expense | View |
| Restricted Cash and Cash Equivalents | View |
| Restricted Cash, Current | View |
| Restricted Cash, Noncurrent | View |
| Retained Earnings (Accumulated Deficit) | View |
| Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | View |
| Stockholders' Equity Attributable to Parent | View |
| Stockholders' Equity Note, Stock Split, Conversion Ratio | View |
| Stock Issued During Period, Value, Employee Stock Purchase Plan | View |
| Stock Issued During Period, Value, New Issues | View |
| Stock Issued During Period, Value, Stock Options Exercised | View |
| Unrecognized Tax Benefits | View |
| Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | View |
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |
| Debt Securities, Available-for-sale, Allowance for Credit Loss | View |
| Proceeds from Sale and Maturity of Marketable Securities | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | View |
| Deferred Revenue, Current | View |
| Deferred Revenue, Noncurrent | View |
| Increase (Decrease) in Deferred Revenue | View |
| Other Liabilities, Noncurrent | View |
| Revenues | View |
| Earnings Per Share, Basic | View |
| Earnings Per Share, Diluted | View |
| Weighted Average Number of Shares Outstanding, Diluted | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| Deferred Tax Assets, in Process Research and Development | View |
| Other Assets, Current | View |
| Prepaid Expense, Current | View |
| Debt Securities, Available-for-sale | View |
| Deferred Costs, Current | View |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | View |
| Debt Securities, Available-for-sale, Noncurrent | View |
| Common Stock, Shares, Outstanding | View |
| Deferred Tax Assets, Tax Credit Carryforwards, Research | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Defined Contribution Plan, Cost | View |
| Other Accrued Liabilities, Current | View |
| OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | View |
| Interest Expense | View |
| Number of Reportable Segments | View |
| 4203377 | View |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | View |